The COVID-19 pandemic has seen the global mobilisation of diagnostics: predominantly rapid tests and lab-based molecular tests. The deployment of laboratory molecular testing...
The importance of processing data from lateral flow rapid tests while recording the exact GPS position
At present, owing to the new COVID-19 virus, the need to deploy novel diagnostics solutions in great numbers and quickly has never been...
Learn the crucial reasons why scale-up should be considered early in the assay development process.
Aiding supply and demand in potential disruptive periods such as the current COVID-19 outbreak.
Watch this animation and look inside a rapid test to see how lateral flow diagnostic technology works.
Learn about the key changes to the In Vitro Diagnostic Directive and the areas you should be actively considering.
Learn about some of the technical considerations for selecting antibodies during lateral flow assay development.
Nina Garrett, Head of Assay Development, looks at the technical considerations when starting a lateral flow project.
mHealth Software Regulation: part II: Regulations for mHealth in the USA, the largest diagnostic market.
mHealth Software Regulation: part I: European regulation surrounding the rapid growing mHealth market.